| Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 489.80 mm | 489.80 mm | 489.80 mm | 489.80 mm | 489.80 mm | 489.80 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 302.97 mm | 195.21 mm | (no burn) | (no burn) |
| Cash used (since last report) | n/a | n/a | 753.22 mm | 485.31 mm | n/a | n/a |
| Cash remaining | n/a | n/a | -263.42 mm | 4.49 mm | n/a | n/a |
| Runway (months of cash) | n/a | n/a | -0.9 | 0.0 | n/a | n/a |
| 13F holders | Current |
|---|---|
| Total holders | 441 |
| Opened positions | 77 |
| Closed positions | 63 |
| Increased positions | 143 |
| Reduced positions | 142 |
| 13F shares | Current |
|---|---|
| Total value | 5.70 tn |
| Total shares | 19.83 mm |
| Total puts | 11.50 k |
| Total calls | 15.70 k |
| Total put/call ratio | 0.7 |
| Largest owners | Shares | Value |
|---|---|---|
| BlackRock | 2.01 mm | $660.85 bn |
| Vanguard | 1.92 mm | $630.68 bn |
| Wealthfront Advisers | 1.04 mm | $37.64 bn |
| Veritas Asset Management | 976.83 k | $320.90 bn |
| Dimensional Fund Advisors | 746.12 k | $245.11 bn |
| Van Eck Associates | 723.47 k | $237.67 mm |
| First Eagle Investment Management | 713.51 k | $234.39 bn |
| STT State Street | 690.17 k | $226.71 bn |
| Earnest Partners | 618.05 k | $203.04 bn |
| Ariel Investments | 560.52 k | $184.14 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Mar 25 | Jonathan P. DiVincenzo | NQSO Bio-Rad A Common Stock | Grant | Acquire A | No | No | 256.45 | 4,863 | 1.25 mm | 4,863 |
| 3 Mar 25 | Sedat Evran | NQSO Bio-Rad A Common Stock | Grant | Acquire A | No | No | 256.45 | 2,918 | 748.32 k | 2,918 |
| 3 Mar 25 | Colleen Corey | NQSO Bio-Rad A Common Stock | Grant | Acquire A | No | No | 256.45 | 1,946 | 499.05 k | 1,946 |
| 3 Mar 25 | Eva Anette Engelhardt | NQSO Bio-Rad A Common Stock | Grant | Acquire A | No | No | 256.45 | 2,918 | 748.32 k | 2,918 |
| 3 Mar 25 | Courtney C Enloe | NQSO Bio-Rad A Common Stock | Grant | Acquire A | No | No | 256.45 | 1,946 | 499.05 k | 1,946 |
